Physician profile
Amit Monga
NPI 1700021805
$7,297.93
in general payments reported to CMS, 2019-2025
55 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $778 · 2021: $847 · 2022: $778 · 2023: $888 · 2024: $1,020 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,014 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,013.63 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,785.80 | 2019-2025 | |
| Amgen INC. | $1,191.49 | 2019-2025 | Evenity, Repatha, Repatha |
| Astellas Pharma US INC | $552.67 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $389.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $287.53 | 2019-2025 | |
| Glaxosmithkline, LLC. | $255.54 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $219.98 | 2019-2025 | |
| Abbott Laboratories | $184.79 | 2019-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $163.60 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Radius Health, INC. | $130.72 | 2019-2025 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $129.66 | 2023-2025 | Rexulti |
| Novo Nordisk INC | $128.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $124.35 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $115.55 | 2025 | Gemtesa |
| Astrazeneca Pharmaceuticals Lp | $104.51 | 2020-2025 | Breztri, Lokelma, Airsupra |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Monga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.